NAD+ for Weight Loss: What Human Trials Show

Disclosure: This post contains affiliate links. We may earn a commission if you purchase through our links, at no extra cost to you.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

NAD+ for weight loss is a popular idea, but the human evidence does not show that NAD+ causes weight loss. The NMN and nicotinamide riboside trials have mostly been small and short. Their weight results run from no change to a small drop. NAD+ injections and IV drips have no controlled weight loss trials behind them in the PubMed searches run for this page, and the FDA-approved weight loss medicines are a separate category with far larger studies.

I’m Judy, I’m not a medical professional, and this page is built from published research and FDA labels, not from personal results. Every health claim below links to the source it came from, and where the evidence is small or short I say so in the same sentence. If you’re a woman over 40 who has heard NAD+ pitched as the missing piece, this is what the research does and doesn’t say.

Table of Contents

Does NAD+ Cause Weight Loss?

No, the research does not show that. A 2023 meta-analysis in Frontiers in Nutrition pooled 22 treatment arms with 5,144 participants and found no significant effect of NAD+ precursor supplements on body weight. A 2026 meta-analysis of oral NMN trials also found no significant effect on body weight or BMI.

Some smaller trials did report small changes, which I walk through below with the group studied and the length of each trial. None of them is a weight loss trial of NAD+ itself.

What Is NAD+ and Why Is It Linked to Weight Loss?

NAD+ (nicotinamide adenine dinucleotide) is a molecule your cells use in energy metabolism. The weight loss pitch rests on a chain of reasoning: NAD+ supports metabolism, NAD+ falls with age, so topping it up might help the body burn fat. Each link in that chain has less support in people than it does on a clinic website.

What does NAD+ do in cells and energy production?

A 2012 paper in Cell Metabolism describes NAD+ as a rate-limiting cosubstrate for the sirtuin enzymes, which help regulate oxidative metabolism. That is basic cell biology, and it is one reason NAD+ gets tied to fat metabolism in marketing.

Do NAD+ levels fall with age?

A 2026 systematic review in Ageing Research Reviews says NAD+ declines with age, and that decline is what motivated NAD-boosting strategies. The same review found that in humans, effects on metabolic, vascular and other healthspan outcomes were mixed and often null. A lower level of a molecule does not prove that replacing it changes your weight.

What do animal studies show about NAD+ and fat?

Mouse results point in both directions. A 2012 study reported that nicotinamide riboside (NR) protected mice against high-fat diet-induced obesity. A 2021 study in the Journal of Endocrinology gave NR for 8 weeks to mildly obese mice of two strains and found no influence on body or organ weight, glucose metabolism, hepatic lipid accumulation or energy expenditure, though it did increase mitochondrial respiration in one muscle. The 2026 review above says rodent effects varied across models and endpoints. Mouse studies are the starting point for the idea, not evidence about women.

What Do Human Studies Show About NAD+ Supplementation and Weight Loss?

The human trials tested precursors the body can turn into NAD+, namely NMN, NR, and the vitamin B3 forms nicotinic acid and nicotinamide. The 2026 review above says oral NR and NMN consistently raised NAD-related metabolites in blood or cells, but that is a measurement, not a weight outcome.

What do pooled trials say about NAD+ precursors and body weight?

The 2023 Frontiers in Nutrition analysis found that NAD+ precursor supplementation lowered BMI by 0.19 kg/m2 on average compared with control groups, and raised adiponectin levels. It found no significant effect on body weight or leptin. For scale, 0.19 BMI points is a little over one pound for a woman who is 5 feet 5 inches tall. The review pooled trials of nicotinic acid and nicotinamide, so it does not tell you what NMN or NR do, and the BMI drop was larger with nicotinic acid than with nicotinamide.

What do NMN trials show for body weight?

The 2026 meta-analysis in Nutrients included 15 randomized trials of oral NMN, with doses of 250 to 2,000 mg a day and durations from 14 days to 24 weeks. It found no significant effects on body weight, BMI, fasting glucose, HbA1c, lipid profiles or systolic blood pressure, and its authors called broad metabolic benefits not evident. Diastolic blood pressure dropped slightly.

One smaller trial points the other way. In a 28-day randomized trial, 30 overweight or obese adults aged 45 and older took two 500 mg NMN tablets twice daily, and their body weight changed by 1.9 kg more than the placebo group’s (95% confidence interval 0.5 to 3.3 kg), falling on NMN and rising on placebo, with 21 people on NMN and 9 on placebo. That study was a physiologic study of safety and body effects, not a weight loss trial, and its authors said the results give the rationale for larger trials.

What happened in postmenopausal women?

A 10-week, double-blind trial gave NMN or placebo to postmenopausal women with prediabetes who were overweight or obese. NMN improved insulin sensitivity in skeletal muscle compared with placebo. In the full paper, 25 women were measured (12 on placebo, 13 on NMN, with average ages of 61 and 62), and body weight, BMI and fat mass did not change differently between the groups. That is the closest trial to the women this page is for, and it is small and short.

What happened in NR trials in people with obesity?

A 12-week trial in 40 men with a BMI over 30 gave NR at 1,000 mg twice daily or placebo and found no improvement in insulin sensitivity and no effect on resting energy expenditure, fat breakdown or body composition. A 6-week crossover trial in 13 overweight or obese men and women gave NR at 1,000 mg a day and found fat-free mass about 1.3 percentage points higher than on placebo, plus a higher sleeping metabolic rate, with no effects on insulin sensitivity or the other metabolic measures tested. The authors called the changes minor.

Two small trials, two different body composition results. Neither was a weight loss trial, and in the 6 week trial body weight did not change (85.2 kg on NR, 85.5 kg on placebo).

Do NAD+ Injections or IV Therapy Help You Lose Weight?

The precursor trials above gave NMN or NR by mouth, not NAD+ by injection or IV. The 2026 Ageing Research Reviews analysis found no eligible outcomes trials of intravenous or intramuscular NAD+ itself for anti-aging or wellness, and it called for larger randomized trials of injected approaches. Searches of PubMed on October 19, 2026 for injected or intravenous NAD+ in humans with weight loss, obesity or body weight outcomes returned no controlled trial.

That means a clinic that promises weight loss from NAD+ injections is going beyond the published human evidence. What people report from injections, and what is and isn’t established, is covered in my guide to NAD+ injection benefits, and the safety questions are in my page on NAD+ side effects.

Is NAD+ FDA Approved for Weight Loss?

No. NIDDK’s page on prescription medications to treat overweight and obesity (last reviewed June 2024) names six FDA-approved drugs for long-term weight management: orlistat, phentermine-topiramate, naltrexone-bupropion, liraglutide, semaglutide (Wegovy) and tirzepatide (Zepbound). NAD+ does not appear anywhere on that page.

NAD+ does show up on a different FDA list. The agency’s 503A bulk drug substances list (updated May 14, 2026) puts Nicotinamide Adenine Dinucleotide (NAD) and its reduced form NADH in category 1, Bulk Drug Substances Under Evaluation. That is an evaluation category for compounding, not an approval of NAD+ as a weight loss treatment.

How Does NAD+ Compare With FDA-Approved Weight Loss Medications?

They are not in the same evidence league, and the difference is worth seeing in numbers.

What do the Wegovy and Zepbound labels say?

The Wegovy label (revised June 2026) says it is indicated, along with a reduced calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction long term in adults with obesity, or adults with overweight who have at least one weight-related condition. The Zepbound label (revised August 2026) carries the same weight reduction indication for adults, plus treatment of moderate to severe obstructive sleep apnea in adults with obesity.

What did the large trials show?

In the STEP 1 trial, 1,961 adults with overweight or obesity and no diabetes received semaglutide 2.4 mg or placebo for 68 weeks along with lifestyle intervention. Average body weight fell 14.9% on semaglutide and 2.4% on placebo. In the SURMOUNT-1 trial, 2,539 adults with obesity, or overweight plus a weight-related complication, and no diabetes took tirzepatide or placebo for 72 weeks. Average weight fell 15.0% to 20.9% across the three tirzepatide doses and 3.1% on placebo. These trials had different designs and populations than the NAD+ studies, so use them as a sense of scale, not a head-to-head comparison.

What do those medicines come with?

Both labels carry a boxed warning about the risk of thyroid C-cell tumors seen in rodents, and both say the medicine is contraindicated in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. NIDDK adds that these medications don’t replace physical activity and healthy eating habits and work best alongside a lifestyle program. Whether any prescription medicine is right for you is a decision for your prescriber.

What Should Women Over 40 Take From the NAD+ Research?

Here’s where the evidence stands, taking each type of study in turn.

Pooled analyses of precursor trials show no significant body weight effect. The one trial in postmenopausal women with prediabetes showed a muscle insulin sensitivity change and no change in weight or fat mass. The two small trials that showed changes lasted 28 days and 6 weeks and enrolled 30 and 13 people. Injections and IV NAD+ have no controlled weight loss trials. The approved medicines have the large trials, and they come with warnings that a clinician has to weigh against your health history.

If fatigue or a stalled scale is what sent you looking at NAD+, raise those with your clinician directly.

If You Want to Ask About NAD+ Therapy

If you decide to look into NAD+ therapy anyway, a licensed clinician should decide whether it is right for you, not a product page. Shed’s NAD+ page, as of October 19, 2026, describes NAD+ nasal spray and injections under a longevity heading. Its four steps are an online medical questionnaire, choosing a program and checking out, a member success manager, and a licensed provider’s review, with medication shipped only if you are approved. See Shed’s NAD+ page here. The benefits list on that page includes metabolism, slowed aging and boosted energy and does not include weight loss, and the research above does not establish those benefits for injections or nasal spray. If cost is your sticking point, I break down how much NAD+ therapy costs, and if you’re comparing it with the oral route, my page on NAD+ vs NMN covers the difference.

Talk to Your Clinician Before You Try Anything

This page is research, not medical advice, and I can’t tell you what is safe for your body. Your medications, thyroid history, pregnancy plans and health conditions all change what makes sense. Take this page and the studies linked below to your prescriber and ask what they mean for you.

Frequently Asked Questions

Does NAD+ help you lose weight?

Not on the evidence so far. Pooled analyses of NAD+ precursor trials found no significant effect on body weight, and the small trials that show a change are short and limited to specific groups. If weight is the goal, a licensed clinician can walk you through options that have large trials behind them.

Is NAD+ FDA approved for weight loss?

No. NAD+ does not appear on NIDDK’s page of FDA-approved weight management drugs, and FDA’s compounding list places NAD in category 1, Bulk Drug Substances Under Evaluation. That is an evaluation category, not an approval.

Do NAD+ injections work for weight loss?

Controlled human trials of injected or IV NAD+ for weight loss do not appear in PubMed searches run on October 19, 2026. A 2026 systematic review also found no outcomes trials of intravenous or intramuscular NAD+ for anti-aging or wellness, so any weight loss promise for injections is ahead of the evidence.

Is NAD+ better than Wegovy or Zepbound for weight loss?

The evidence does not put them on the same footing. Wegovy and Zepbound have FDA labels for weight reduction and randomized trials of 1,961 and 2,539 adults, while NAD+ precursors have small, short trials with mixed weight results. Those medicines also carry boxed warnings, so the choice belongs with a prescriber.

Can NAD+ replace diet and exercise?

No evidence says it can. NIDDK states that even FDA-approved weight management medications don’t replace physical activity or healthy eating habits, so a supplement with weaker evidence can’t be assumed to do what medication does not.

What is NAD+ and why do people link it to weight loss?

NAD+ is a molecule cells use in energy metabolism. One source of the weight loss idea is mouse studies, where NAD+ precursors sometimes protected against diet-induced obesity and sometimes had no effect on weight. Human trials have not confirmed it.

Sources

NAD+ for Weight Loss: What Women Over 40 Should Know